D. Scott

Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus

N. Wray, H. Gabra, H. Newbery, 2007, British Journal of Cancer.

Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers.

D. Scott, F. May, B. Westley, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

High expression of the trefoil protein TFF1 in interval breast cancers.

D. Scott, F. May, B. Westley, 2001, The American journal of pathology.

Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells

Dong Xie, Carl W. Miller, Carl Miller, 2005, Clinical Cancer Research.

WWOX: A candidate tumor suppressor gene involved in multiple tumor types

D J Porteous, D. Porteous, A. Paige, 2001, Proceedings of the National Academy of Sciences of the United States of America.

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear.

A. Paige, H. Gabra, J. Smyth, 2005, International journal of oncology.

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer

P. Bates, H. Gabra, B. Contreras-Moreira, 2003, Nature Genetics.

The IgLON Family in Epithelial Ovarian Cancer: Expression Profiles and Clinicopathologic Correlates

H. Gabra, J. Smyth, D. Scott, 2005, Clinical Cancer Research.

Presence and quantification of macrophages in squamous cell carcinoma of the cervix

W. Lambert, J. Skurnick, D. Scott, 2002, International Journal of Gynecologic Cancer.

Demonstration of Her-2 Protein in Cervical Carcinomas

J. Skurnick, M. Hameed, D. Scott, 2003, Journal of lower genital tract disease.